Data / Form D filings / NAPO PHARMACEUTICALS INC
NAPO PHARMACEUTICALS INC: Form D filings
NAPO PHARMACEUTICALS INC, a pharmaceuticals company in San Francisco, CA, filed 5 Form D notices with the SEC between 2009 and 2014. The latest, on June 6, 2014, reports $137,500 sold of a $137,500 offering to 3 investors.
Find out what NAPO PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 185 BERRY STREET, SUITE 1300, San Francisco, CA, 94107
- Phone
- (415) 371-8300
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1188290
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 6, 2014 | New notice | $137,500 | $137,500 | $0 | 3 | Mar 18, 2014 | sec.gov |
| Oct 27, 2011 | New notice | $5,000,000 | $3,087,500 | $1,912,500 | 5 | Jul 6, 2011 | sec.gov |
| Jun 22, 2011 | New notice | $6,000,000 | $2,996,869 | $3,003,131 | 10 | Feb 17, 2011 | sec.gov |
| Oct 27, 2010 | New notice | $8,900,000 | $3,360,000 | $5,540,000 | 10 | Jun 7, 2010 | sec.gov |
| Jul 9, 2009 | New notice | $500,000 | $500,000 | $0 | 1 | May 12, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joshua Mailman | Director | |
| Gregory Stock | Director | |
| Steven King | Executive Officer | |
| Richard Fields | Director | |
| Lisa Conte | Executive Officer, Director | |
| Thomas Van Dyck | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jun 2, 2014 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what NAPO PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.